An increase in circulating levels of sFlt1 (soluble FMS-like tyrosine kinase 1) and downregulation of PIGF (placental growth factor) levels are diagnostic markers, which assist in the early diagnosis of preeclampsia [8,9]. This evidence concerns the gene PIGF and preeclampsia.